Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 1972-2 is a non-coding RNA gene that encodes a ~22-nucleotide microRNA involved in post-transcriptional regulation of gene expression. Like other microRNAs, miR-1972-2 is processed from a primary transcript, incorporated into the RNA-induced silencing complex (RISC), and regulates gene expression typically by binding imperfectly to target mRNAs, resulting in translational repression or degradation. Research in cell lines suggests miR-1972 may regulate genes involved in proliferation, metastasis, and angiogenesis—especially impacting breast cancer cell migration and growth as well as expression of angiogenesis markers and von Willebrand factor (VWF). No drugs have been documented to directly interact with MIR1972-2; however, experimental use of microRNA mimics or inhibitors is ongoing in research contexts.
Gene silencing via RNA-induced silencing complex (RISC); Translational inhibition or target mRNA destabilization through imperfect base-pairing with mRNA's 3' UTR.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 1972-2 (miR-1972-2).